Correlation Between NYSE Composite and Xeno Transplants
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Xeno Transplants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Xeno Transplants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Xeno Transplants, you can compare the effects of market volatilities on NYSE Composite and Xeno Transplants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Xeno Transplants. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Xeno Transplants.
Diversification Opportunities for NYSE Composite and Xeno Transplants
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Xeno is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Xeno Transplants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeno Transplants and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Xeno Transplants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeno Transplants has no effect on the direction of NYSE Composite i.e., NYSE Composite and Xeno Transplants go up and down completely randomly.
Pair Corralation between NYSE Composite and Xeno Transplants
If you would invest 1,898,790 in NYSE Composite on September 12, 2024 and sell it today you would earn a total of 90,313 from holding NYSE Composite or generate 4.76% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Xeno Transplants
Performance |
Timeline |
NYSE Composite and Xeno Transplants Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Xeno Transplants
Pair trading matchups for Xeno Transplants
Pair Trading with NYSE Composite and Xeno Transplants
The main advantage of trading using opposite NYSE Composite and Xeno Transplants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Xeno Transplants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeno Transplants will offset losses from the drop in Xeno Transplants' long position.NYSE Composite vs. Boston Beer | NYSE Composite vs. Freedom Bank of | NYSE Composite vs. KeyCorp | NYSE Composite vs. LithiumBank Resources Corp |
Xeno Transplants vs. Ventyx Biosciences | Xeno Transplants vs. Keros Therapeutics | Xeno Transplants vs. Crinetics Pharmaceuticals | Xeno Transplants vs. Vaxcyte |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |